Review this module by Fadi Ghassan Haddad MD discussing chronicphase chronic myeloid leukemia treatment including optimal therapy selection strategies to optimize treatmentfree remission and overcoming resistance to TKI therapy
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/hematology/chronic-myeloid-leukemia-treatment/22499-47035
- Start Date: 2024-08-15 05:00:00
- End Date: 2024-08-15 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 99997.0 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 80000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest